Cochlear Limited
Cochlear Limited (CHEOY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cheoy · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Cochlear Limited (CHEOY) measures how much investors pay for each dollar of the company's trailing earnings. CHEOY's current PE ratio of 19.45x is calculated by dividing its stock price of $35.07 by its TTM earnings per share of $5.28. −61.9% discount vs 5Y avg 51.1x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2013 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 12 fiscal years · Front-end computedMinQ1 · 25%44.5x
MedianQ3 · 75%59.3x
Max
At 19.45x, CHEOY's current P/E is lower than in 0% of its annual fiscal year readings over the past 12 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Cochlear LimitedYou CHEOY | $4.6B | 19.45x | -31.2% | $5.28 |
 Alibaba Health Information Technology Limited ALBBY | $7.3B | 29.76x | +5.3% | $2.33 |
 Bangkok Dusit Medical Services Public Company Limited BDUUY | $10.0B | 20.12x | -28.9% | $38.24 |
 CSPC Pharmaceutical Group Limited CHJTF | $12.0B | 22.34x | -21.0% | $0.33 |
 Eurofins Scientific SE ERFSF | $12.7B | 23.65x | -16.4% | $2.64 |
 Fisher & Paykel Healthcare Corporation Limited FSPKF | $13.2B | 49.69x | +75.7% | $0.81 |
 Sonova Holding AG SONVF | $15.9B | 24.11x | -14.7% | $7.11 |
Industry Average 6 peers with valid PE | — | 28.28x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | 50.44x | $2.97 | -15.0% | |
2024-06-30 FY2024 | 59.33x | $2.71 | +18.1% | |
2023-06-30 FY2023 | 50.22x | $2.29 | +11.8% | |
2022-06-30 FY2022 | 44.93x | $2.20 | -11.1% | |
2021-06-30 FY2021 | 50.56x | $2.48 | — | |
2020-06-30 FY2020 | — | $-2.00 | — | |
2019-06-30 FY2019 | 43.99x | $2.40 | -5.0% | |
2018-06-30 FY2018 | 46.32x | $2.14 | +14.1% | |
2017-06-30 FY2017 | 40.59x | $1.95 | +10.1% | |
2016-06-30 FY2016 | 36.87x | $1.65 | +17.1% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Cochlear Limited (CHEOY) measures how much investors pay for each dollar of the company's trailing earnings. CHEOY's current PE ratio of 19.45x is calculated by dividing its stock price of $35.07 by its TTM earnings per share of $5.28.
Frequently asked questions
CHEOY pe ratio · 6 questionsCHEOY's current PE ratio is 19.45x as of 2026-06-09, based on a stock price of $35.07 and TTM EPS of $5.28. Data sourced from Financial Modeling Prep via CHEOY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cochlear Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09